Advertisement Almac launches Late Stage Customisation Suite - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Almac launches Late Stage Customisation Suite

Almac has added an additional Late Stage Customisation Suite to its commercial facilities to support its clients with their EU product launches, reduce stock holdings and provide greater flexibility with regional packs.

Almac said that assembling regional packs results in one pack being available for as many as five markets, as country specific information is applied to the ‘Blue Box’ area as orders are received direct from pharmacies or hospitals.

The addition of the Late Stage Customisation Suite gives Almac the flexibility to process these orders immediately ensuring just-in-time delivery.

Almac distribution manager Mark English said that grouping countries by language allowing for multilanguage packs to service multiple markets, with country specific information added at point of despatch, provides significant cost advantages.

"Working with products that are manufactured in very low volumes at, often, a very high cost means that solutions to minimise stock holding are of particular benefit," English said.

Almac Commercial Operations VP David Downey said that with their client partners, they have successfully launched many high-value, orphan drug / niche products into the European market, hitting launch timelines, and maximising product flexibility to supply multiple markets.

"Utilising our integrated pharmaceutical and distribution services we can provide a seamless transfer of product and services to the end-user," Downey said.